Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Several fundamental issues around the use of pressure risk
scales are highlighted by the article by Schoonhoven et al.1
These scales are poor predictors of pressure ulcer development, but nurses are encouraged to use them to meet the clinical governance agenda. The guidelines from the National Institute for Clinical Excellence recommend their use as an aide-mémoire, which should not replace clinical judgment.2 Nurses should not rely on these scales, but they do at least offer a framework for assessment, unlike clinical judgment. The evidence from the study by Schoonhoven et al is that these tools may have some value in detecting patients who will develop pressure ulcers, but with a high number of false positive responses.
This has resource implications in providing prevention strategies for
patients who will not develop pressure ulceration. Using the Braden
scale, we calculate that 728 of the 2190 patient weeks (33%) would
require measures to